Omics analysis of uveal melanoma: Leukocyte gene signatures reveal novel survival distinctions and indicate a prognostic role for cytolytic activity scoring

Objective: The significant metastatic potential of uveal melanoma (UVM) lends to high mortality. Even with successful local tumor treatment, many patients will develop metastatic disease. The present study aims to elucidate the relationship between tumor-infiltrating immune cell (TIIC) diversity and survival to identify potential therapeutic targets and improve UVM prognosis. Methods: Bulk deconvolution was used to determine the relative proportions of 22 hematopoietic TIIC from 80 UVM tumor samples. Cytolytic activity (CYT) was determined, and associated survival probabilities were mined using time-to-event data. Nominal P-values were subjected to FDR correction. Results: High relative abundance of tumor-infiltrating naïve B cells, resting memory CD4+ T cells, and monocytes correlated with better overall and disease-free survival probability. Low relative abundance of CD8+ T cells correlated with better overall survival and disease-free survival probability. CYT correlated positively with relative abundance of naïve B cells, resting memory CD4+ T cells, and monocytes. CYT correlated negatively with relative abundance of CD8+ T cells. Conclusion: Infiltrating naïve B cells, resting memory CD4+ T cells, monocytes, and CD8+ T cells are potential therapeutic targets in UVM that warrant further investigation. High CYT estimates associate with worse UVM survival outcomes.

[1]  Sherine F. Elsawa,et al.  Macrophage Polarization States in the Tumor Microenvironment , 2021, International journal of molecular sciences.

[2]  Ting Zhang,et al.  Tumor-Associated Macrophages in Tumor Immunity , 2020, Frontiers in Immunology.

[3]  H. Nijman,et al.  Tumor-infiltrating lymphocytes in the immunotherapy era , 2020, Cellular & Molecular Immunology.

[4]  Guihua Tang,et al.  Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme , 2020, Frontiers in Oncology.

[5]  Yunfei Bai,et al.  Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer , 2019, Cancer science.

[6]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[7]  H. Grossniklaus Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis. , 2019, Ophthalmology.

[8]  Huy Q. Dinh,et al.  Monocyte heterogeneity and functions in cancer , 2019, Journal of leukocyte biology.

[9]  A. Portela,et al.  Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma , 2018, Cancer and Metastasis Reviews.

[10]  Xuan Peng,et al.  Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer , 2018, Annals of Surgical Oncology.

[11]  Christodoulos Efstathiades,et al.  The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis , 2018, Front. Oncol..

[12]  Y. Krishna,et al.  Inflammatory cell infiltrates in advanced metastatic uveal melanoma. , 2017, Human pathology.

[13]  Heather H Gustafson,et al.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics. , 2017, Advanced drug delivery reviews.

[14]  B. Stanger,et al.  Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer , 2016, Clinical Cancer Research.

[15]  Wang Min,et al.  Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. , 2016, The Journal of clinical investigation.

[16]  G. Schwartz,et al.  Metastatic disease from uveal melanoma: treatment options and future prospects , 2016, British Journal of Ophthalmology.

[17]  N. Hacohen,et al.  Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.

[18]  Dana M Previte,et al.  Influence of CD8+ T regulatory cells on intraocular tumor development , 2012, Front. Immun..

[19]  C. Shields,et al.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. , 2009, Archives of ophthalmology.

[20]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[21]  T. Kivelä,et al.  Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. , 2000, Ophthalmology.

[22]  L. Karnell,et al.  The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.

[23]  I. McLean,et al.  Uveal melanoma , 1997, Cancer.

[24]  M. Burnier,et al.  Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. , 1993, Investigative ophthalmology & visual science.

[25]  B. Damato,et al.  Analysis of lymphocytic infiltration in uveal melanoma. , 1990, Investigative ophthalmology & visual science.

[26]  Ash A. Alizadeh,et al.  Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.

[27]  James R. Downing,et al.  Annual review of pathology : mechanisms of disease , 2006 .

[28]  C. Mignogna,et al.  Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? , 2006, International journal of immunopathology and pharmacology.

[29]  I. McLean,et al.  Lymphocytic infiltration in uveal malignant melanoma , 1990, Cancer.